A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease

Conditions

• COPD

Interventions

• DRUG: Part A: RPL554
• DRUG: Placebos
• DRUG: Part B: RPL554

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Collaborators

• [object Object]